• No se han encontrado resultados

William Dager and lenana Haliovie

N/A
N/A
Protected

Academic year: 2018

Share "William Dager and lenana Haliovie"

Copied!
6
0
0

Texto completo

(1)

Contributors . . . .xiii Foreword. . . xxvii

Foreword to the First Edition .xxix

Preface . . . xxxi

SECTION 1

Foundation Issues

Section Editor: L. Michael Posey

1. Pharmacoeconomics: Principies,

Methods, and Applications 6) . . . .. 1 Lisa Sanehez Trask

2.

Health Outcomes and Health-Related

Quality of Life

e

3

Stephen Joe/ Coons

3.

Health Literacy and Medication UseCD . . . .. 5 Oralia V. Bazaldua and Sunil Kripalani

4. Cultural Competency CD . . . 7

Jeri J. Sias, Amanda M. Loya, José O. Rivera,

Arthur A. Islas, and Ulysses]. Urquidi

5. Principies and Practices

of Medication Safety CD . . . 9

Seott M. Mark, Jeffrey D. Little, Sarah E. Adkins, and Robert J. Weber

6. Evidence- Based Medicine CD 11

Elaine Chiquette and L. Miehae/ Posey

7.

Documentation of Pharmacy Services (i\ . . . .. 13

George E. MaeKinnon III and Neil J. MaeKinnon

8. Clinical Pharmacokinetics and

Pharmacodynamics e. . . .. 15

Larry A. Bauer

9. Pharmacogenetics (\\ . . . .. 17

Larisa H. Cavallari and Y. W. Francis Lam

10.

Pediatrics

4'

19

Milap C. Nahata and Carol Taketomo

11.

GeriatricsCD oo 21

Emily R. Hajjar, Shelly L. Gray, David R.P. Guay, Catherine 1. Starner, Steven M. Handler, and Joseph T. Hanlon

12.

Palliative Care

.

23

Jill Astolfi

13. Pharmacoepidemiology CD . . . 25

Andy Stergaehis,Thomas K. Hazlet, and Denise Boudreau

14. Clinical Toxicology . . . 27

Peter A. Chyka

1 5. Emergency Preparedness: Identification and

Management of Biologic Exposures

&. . . .

51

Colleen M. Terriff, Jason E. Brouillard, Lisa T. Costanigro, and Jessiea S. Oftebro

16. Emergency Preparedness: Identification and

Management of Chemical and Radiologic

Exposures

~ . . . .

.

. . . .

.

. .

.. . . .53 Greene Shepherd and Riehard B. Sehwartz

SECTION 2

Cardiovascular Disorders

SectionEditor:Robert

L.Talbert

17. Cardiovascular Testing. . . 55

Riehard A. Lange and L. David Hillis

1 8. Cardiac Arrest . . . 83

Jeffrey F. Barletta and Jeffrey L. Wilt

19. Hypertension . . . 101

Joseph J. Saseen and Erie ]. Maclaughlin

20. Systolic Heart Failure . . . .. 137

Robert B. Parker and Larisa H. Cavallari

21.

Diastolic Heart Failure and the

Cardiomyopathies .. . . .. 173

Jean M. Nappi and Robert L. Page II

(2)

22.

Acute Decompensated

Heart Failureo oooooooo ooooooooooooooooooooo oo 191

lo EoRodgers and Craig R. Lee

23. Ischemic Heart Diseaseo . . . . oo oo oo oo oo o. . . 209

Robert L. Talbert

24. Acute Coronary Syndromes. o o o 241

Sarah Ao Spinler and Simon De Denus

25. The Arrhythmias ooooo oooooo o. . . .. . oooooooo oo 273

Cynthia Ao Sanoski and lerry L. Bauman

26.

Venous Thromboembolismo o o o o o.. o o o o o o o o o o 0311 Daniel M. Witt, Edith AoNuteseu,

and Stuart T. Haines

27. Stroke o o o o o . . o o o o o o o o o o o . . . . o . o o o o o o o o o o o o . . 353

Susan C. Fagan and David C. Hess

28. Dyslipidemiao o o o o o o o.. o. o o o o o o o o o o o o o. o. o o o o365

Robert L. Talbert

29.

Peripheral Arterial Disease. . . o o o o o o o o o o . . . o . 389

Barbara J. Hoeben and Robert L. Talbert

30. Use ofVasopressors and

Inotropes in the Pharmacotherapy

of Shock. o o o o o o o o o o o . o o o o o o o o o o o o . . . . o o o o o o o399

Robert Maclaren, Maria lo Rudis, and loseph F. Dasta

31. Hypovolemic Shock. o o o o o o o o o o o... o o o o o o o o o o o 421

Brian L. Erstad

SECTION 3

RespiratoryOisorders

Section Editor: Robert L. Talbert

32. Introduction to Pulmonary

FunctionTesting6) o o o o o o o o o o o o o o o . . . . o o o o o o437

lay l. Peters and Stephanie M. Levine

33. Asthma o o o o . . o o o o . . . o . . . o o o o o 439 H. William Kel/y and Christine Ao Sorkness

34. Chronic Obstructive

Pulmonary Disease . . o o o o o o o o o o o o o o o o o o o o . o o . 471

Dennis M. Williams and Sharya Vo Bourdet

35. Pulmonary Arterial Hypertension . o. . . 497

Rebecca Moote, Rebecca L. Attridge, and Deborah 'o Levine

36. Drug- Induced Pulmonary Disease . . . 511

Hengameh Ho Raissy, Miehel/e Harkins, and Patrieia L. Marshik

37.

Cystic Fibrosis .. .. .. . ooo.. .. . .. .. .. . .. . . o525

ChaninC. Wrightand YolandaY. Vera

SECTION4

Gastrointestinal

Oisorders

SectionEditor:JosephT. DiPiro

38. Evaluation of the Gastrointestinal

Tract. . . oo . . . oo oo . . . oo oo o. . 539

Keith M. Olsen and Grant FoHutehins

39.

Gastroesophageal Reflux Diseaseo o o o o o o . . . o . o o549

Dianne B. Williams and Robert R. Sehade

40.

Peptic Ulcer Disease . . . o o o . . o o o o o o . . o o o o o o . 563

Rosemary R. Berardi and Randolph VoFugit

41. Inflammatory Bowel Disease . . . oo. o. o. 587

Brian Ao Hemstreet

42.

Nausea and Vomitingo o . . . o . o o o . . . . o o o o o o . . . .607 Cecily V. DiPiro and Robert J. 19noffo

43. Diarrhea, Constipation, and Irritable

Bowel Syndrome o o o. 621

Patricia Ho Powel/ and Virginia Ho Fleming

44.

Portal Hypertension and Cirrhosiso o o o o . o o o o o o o 639

lulie Mo Sease

45.

Drug-Induced Liver Disease o. o oo oo . . . oo . . o. . . 659

William R. Kirehain and Rondal/ E. Al/en

46. Pancreatitis. o o o o . . . o . o o o o o o . . . o o o o . . . o o o o o . . 669

Seott Bolesta and PatriciaAoMontgomery

47.

Vira! Hepatitis .. .. .. . oo.. .. .. . ooo.. .. ooo.. . . 685 Paulina Deming

48. Drug Therapy Individualization in Patients with Hepatic Disease and Genetic Alterations in Drug

Metabolizing Activity o. . . ooooo. o. . . o. . . 705 YoWoFrancis Lam

49.

Celiac Disease&.. o o o o o o o o.. o o o 0717

Robert Ao Mangione and Priti N. Patel

SECTION 5

Renal Oisorders

SectionEditor:GaryRoMatzke

50. Clinical Assessment of Kidney Function . . . oo 719 Thomas C. Dowling

51. Acute Kidney Injury . . . o. . . o. . .741 WilliamDager and lenana Hali/ovie

52. Chronic Kidney Disease:

Progression-Modifying Therapieso. o . . . o o o o o o o o767

Vimal K. Derebail, Abhijit Vo Kshirsagar,

and Melanie Soloy

(3)

53. Chronic Kidney Disease:

Management of Complications . . . 787 Joanna Q. Hudson

54. Hemodialysis and Peritoneal Dialysis 6) . . . 817

Kevin M. Sowinski and Mariann D. Churchwell

55. Drug-Induced Kidney Disease. . . 819

Thomas D. Nolin and Jonathan Himmelfarb

56. Glomerulonephritis 837

Alan H. Lau

57.

Drug Therapy Individualization for

Patients with Chronic Kidney Disease. . . 861

Gary R. Matzke

58.

Disorders ofSodium and Water

Homeostasis . . . 873

James D. Coyle and Gary R. Matzke

59. Disorders of Calcium and Phosphorus

Homeostasis. . . 891

Amy Barton Pai

60.

Disorders of Potassium and Magnesium

Homeostasis. . . 909

Donald F. Brophy and Jane Frumin

61. Acid-Base Disorders . . . 923

John W. Devlin and Gary R. Matzke

-,

, '.,

.

~..

Neurologlc Disorders

Section Editor: Barbara G. Wel/s

62. Evaluation ofNeurologic Illness 943

Susan C.Fagan and Fenwick T. Nichols

63. Alzheimer's Disease. . . 947

Patricia W. Slattum, Russell H. Swerdlow,

and Angela Massey Hill

64. Multiple Sclerosis. . . .. . . 963

Jacquelyn L. Bainbridge and John R. Corboy

65. Epilepsy . . . 979

Susan ]. Rogers and Jose E. Cavazos

66. Status Epilepticus. . . 1007 Stephanie]. Phelps,Collin A. Hovinga,

and James

w.

Wheless

67.

Acute Management ofthe

Brain Injury Patient. . . 1019

Bradley A. Boucher and Shelly D. Timmons

68. Parkinson's Disease. . . 1033

Jack]. Chen, Merlin V.Nelson,

and David M. Swope

69. Pain Management . . . 1045

Terry J. Baumann, Jennifer M. Strickland, and Chris M. Herndon

70. Headache Disorders . . . 1061

Deborah S. Minor

SECTION 7

psychiatric Disorders

Section Editor: Barbara G. Wel/s

71.

Evaluation of Psychiatric Illness . . . .. 1077

MarkE. Schneiderhan, Leigh Anne Nelson,

and Stuart Munro

72. Childhood Disorders. . . .1087

Julie A. Dopheide and StephenR. Pliszka

73.

Eating Disorders 1101

Steven C. Stoner

74. Substance-Related Disorders:

Overview and Depressants, Stimulants,

and Hallucinogens. . . 1113

Paul L. Doering

75. Substance-Related Disorders: Alcohol,

Nicotine, and Caffeine .. . . .. 1131

PaulL. Doeringand RobinMoorman U

76.

Schizophrenia . 1147

M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley

77.

Major Depressive Disorder 1173

Christian]. Teter, Judith C. Kando, and Barbara G. Wells

78. Bipolar Disorder . . . 1191

Shannon J.Drayton

79. Anxiety Disorders 1: Generalized Anxiety, Panic,

and Social Anxiety Disorders. . . 1)09

Sarah T. Melton and Cynthia K. Kirkwood

80.

Anxiety Disorders 11: Posttraumatic Stress Disorder and Obsessive-Compulsive

Disorder. . . .. 1229

CynthiaK. Kirkwood, Usa B. Phipps, and Barbara G. Wells

81. Sleep Disorders. . . .. . . .. 1241 JohnM. Dopp and Bradley G. Phillips

82. Disorders Associated with

Intellectual Disabilities

8

. . . 1253 Nancy Brahm,Jerry Mckee, and Douglas Stewart

(4)

SECTION

8

Endocrinologic Disorders

Section Editor: Robert L. Talbert

83. Diabetes Mellitus. . . 1255

Curtis 1. Triplitt and CharlesA. Reasner

84. Thyroid Disorders. . . 1303 JacquelineJonklaas and Robert 1. Talbert

85. Adrenal Gland Disorders 1327

Steven M. Smith and John G. Gums

86.

Pituitary Gland Disorders . . . 1345 Amy Heck Sheehan, Jack A. Yanovski,

and Karim Anton Calis

SECTION

9

Gynecologic and Obstetric

Dlsorders

SectionEditor: Barbara C. We/ls

87. Pregnancy and Lactation:

Therapeutic Considerations. . . 1361 Kristina E. Ward and Barbara M. O'Brien

88. Contraception . . . 1377 Sarah P. Shrader, Kelly R. Ragucci,

and VanessaA. Diaz

89. Menstruation-Related Disorders. . . .. 1393

Elena M. Umland, Lara Carson Weinstein, and Edward M. Buchanan

90. Endometriosis . . . 1409

Deborah A. Sturpe

91.

Hormone Therapy in Women 1417

Sophia N. Kalantaridou, Devra K. Dang,

Susan R. Davis, and Karim Anton Calis

SECTION 10

UrologicDisorders

Section Editor: L. Michael Posey

92. Erectile Dysfunction . . . 1437

Mary Lee

93. Benign Prostatic Hyperplasia. . . 1455 Mary Lee

94. Urinary Incontinence . . . 1467 Eric S. Rovner, Jean Wyman,

Thomas Lackner, and David R.P. Guay

SECTION 11

Immunologic Disorders

SectionEditor:Cary

e Yee

95. Function and Evaluation of the

Immune System . . 1487

PhilipD. Hall,NicoleWeimertPilch, and DanielH. Atchley

96. Systemic Lupus Erythematosus and

Other Collagen-Vascular Disorders 1505

JeffreyC. Delafuenteand KimberlyA. Cappuzzo

97. Allergic and Pseudoallergic

Drug Reactions. . . 1521

Lynne M. Sylvia and Joseph T. DiPiro

98. Solid-Organ Transplantation. . . .. 1537

Heather j. Johnson and Kristine S. Schonder

~'l 3 jr'11tnlngic Disorderc;

SectionEditor:L. Michael Posey

~~ Osteoporosis and Other Metabolic

Bone Diseases. . . 1559

Mary Beth O'Connell and Sheryl F. Vondracek

00 Rheumatoid Arthritis ... . . . 1583

Arthur A. Schuna

101 Osteoarthritis 1599

Lucinda M. Buys and Mary Elizabeth Elliott

01. Gout and Hyperuricemia. . . .. 1621 Michael E. Ernst and ElizabethC. Clark

SECTION 13

Ophthalmicand OtolaryngologicalDisorders

Section Editor: L. Michael Posey

103.

Glaucoma . . . 1633

Richard G. Fiscella, Timothy S. Lesar, and Deepak P. Edward

104. Allergic Rhinitis. . . 1649

j. RussellMay and Philip H. Smith

SECTION 14

Dermatologic Disorders

SectionEditor:L. Michael Posey

105.

Dermatologic Drug Reactions

and Common Skin Conditions.. 1661

Rebecca M. Law and David T.S. Law

(5)

1 06. Acne V ulgaris. . . . .. . . .. . . 1673

Debra J. Sibbald

107.

Psoriasis 1693

Rebecca M. Law and Wayne P. Gul/iver

108. Atopic Dermatitis . . . 1707

Rebecca M. Law and Po Gin Kwa

SECTION 15

Hematologic Disorders

Section Editor: Gory C. Yee

109. Anemias 1717

KristenCook,BeataA. lneck,and William1. Lyons

11O.

Coagulation Disorders . . . 1741

Betsy Bickert Poon, Char Witmer, and Jane Pruemer

111. Sickle Cell Disease . . . .. 1765

C. Y. Jennifer Chan and Reginald Moore 112. Drug-Induced Hematologic

Disorders. . . 1781

Christine N. Hansen and Amy F. Rosenberg

SECTION 16

Infectious Diseases

SectionEditor:Joseph T.DiPiro

113.Laboratory Tests to Direct Atimicrobial

Pharmacotherapy. . . 1797

Michael J.Rybak, Jeffrey R. Aeschlimann,

and Kerry 1. Laplante

114. Antimicrobial Regimen Selection. . . .1813

David S.Burgess

115. Central Nervous System Infections. . . 1825

Isaac F. Mitropoulos, Elizabeth D. Hermsen, and John C. Rotschafer

116.LowerRespiratory Tract Infections . . . .. 1845

Martha G. Blackford, Mark 1. Glover, and Michael D. Reed

117.

Upper Respiratory Tract Infections . . . .. 1867

Christopher Frei, Bradi Frei, and George Zhanel

118. Influenza. . . .1881

Jessica C. N)oku and Elizabeth D. Hermsen

119. Skin and Soft- Tissue Infections. . . .. 1893

Douglas N. Fish, Susan 1. Pendland, and Larry H. Danziger

120. Infective Endocarditis. . . 1913

Angie Veverka and Michael A. Crouch

121. Tuberculosis. .. . . .. . . 1931

CharlesA. Peloquin and Rocsanna Namdar

122. Gastrointestinal Infections and

Enterotoxigenic Poisonings . . . 1951

Steven Martin and RoseJung

123.

Intraabdominal Infections . . . 1969

Joseph T. DiPiro and Thomas R. Howdieshell

124. Parasitic Diseases. . . 1981

J. V. Anandan

125. Urinary Tract Infections and Prostatitis . . . 1995 Elizabeth A. Coyle and Randall A. Prince

126. Sexually Transmitted Diseases. . . 2011 Leroy C. Knodel

127.

Bone and Joint Infections . 2029

Edward P. Armstrong and Allan D. Friedman

128.

Severe Sepsis and Septic Shock. . . 2041

S. Lena Kang-Birken and Karla Killgore-Smith

129.

Superficial Fungal Infections . . . 2055

Thomas E. R. Brown, Linda D. Dresser, and Thomas W. F. Chin

130. Invasive Fungal Infections . . . 2073

Peggy 1. Carver

131. Infections in Immunocompromised

Patients . . . 2105

Douglas N. Fish

132.

Antimicrobial Prophylaxis in Surgery . . . 2131 Salmaan Kan)i

133. Vaccines, Toxoids, and Other

Immunobiologics. . . 2147

Mary S.Hayney

134. Human Immunodeficiency Virus Infection . . . . 2169

Peter 1. Anderson, Thomas N. Kakuda,

and Courtney V.Fletcher

SECTION

17

Oncologic Disorders

Sedion Editor: Gory C. Yee

135. Cancer Treatment and Chemotherapy .2191

Patrick J. Medina and Stacy S. Shord

136. Breast Cancer . . . 2229

Laura Boehnke Michaud, Chad M. Barnett, and Francisco J. Esteva

137. Lung Cancer. . . 2271

DeborahA. Friezeand ValR.Adams

(6)

138. Colorectal Cancer . . . 2287

Lisa E. Davis, Weijing Sun, and Patrick J. Medina

139. Prostate Cancer . . . 2319

LeAnn B. Norris and Jill M. Ko/esar

140. Lymphomas . . . 2333

A/exandreChanand GaryC. Yee

141. Ovarian Cancer . . . 2361

JudithA. Smith andJudithK. Wolf

142.

Acute Leukemias . . . 2377

Betsy Bickert Poon and Dianne M. Brundage

143. Chronic Leukemias . . . 2401

Christopher A. Fause/ and Patrick ]. Kie/

144. Multiple Myeloma . . . 2417

Timothy R. McGuire and Casey B. Williams

145. Myelodysplastic Syndromes .. . . .2431 Julianna A. Burzynski and Tracey Wa/sh-Choco/aad

146. Renal Cell Carcinoma" . . . 2433

Christine M. Wa/ko, Ninh M. La-Beck. and Mark D. Wa/sh

147. Melanoma. . . 2435

Cindy 1. O'Bryant and Jamie c. Poust

148. Hematopoietic Stem Cell

Transplantation . . . 2455

Janelle B. Perkins and Gary C. Yee

Nutntional

Oisorders

Section Editor:Gary R. Matzke

149. Assessment ofNutrition Status,

and Nutrition Requirements . . . 2473 Katherine Hammond Chessman

and Vanessa]. Kumpf

150. Medication Administration Considerations

with Specialized Nutrition Support . . . 2493

Ro/and N. Dickerson and Gordon S. Sacks

151.

Parenteral Nutrition . . . 2505

Todd W.Mattoxand CatherineM. Crill

J52. Enteral Nutrition . . . 2527

Vanessa ]. Kumpf and Katherine Hammond Chessman

153.

Nutritional Considerations in Major

Organ Failure . . . 2545

Brian M. Hodges and Mark DeLegge

154. Obesity. . . 2567 Judy T. Chen, Amy Heck Sheehan,

JackA. Yanovski, and Karim Anton Calis

Glossary. . . 2585

Referencias

Documento similar

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

Several systems, molecules and responses involved in the pathogenesis of the pathological fibrosis of chronic kidney disease (CKD) will be discussed in this review, putting

Lourdes de León, a Mexican linguistic anthropologist who has worked for over two decades with Mexican Mayan children and families, has explicitly discussed the role her own

Kopple, “Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients,” Clinical Journal of the American Society of Nephrology,

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk

Recent evidence suggests a role for TNF superfamily member Tumor necrosis factor-like weak inducer of apoptosis (TWEAK, Apo3L, or TNFSF12) in both AKI and CKD, where it has been

CHAPTER 5. EVALUATION AND RESULTS 35.. In fact, in all variants of the algorithm, the sequential executions outperform the single work-item executions. The reason for this can be